Deep vein thrombosis (DVT) is a prevalent clinical venous thrombotic condition that often
manifests independently or in conjunction with other ailments. Thrombi have the propensity …

This study is aimed at identifying the roles of AGE/RAGE and ET-1 in deep vein thrombosis
(DVT). Advanced glycation end products (AGEs) in glycated human serum albumin (M-HSA) …

Background Deep vein thrombosis (DVT) is a vascular disease that has no effective
treatment at present. Endothelial cells play a crucial role in the processes vasoconstriction …

Deep venous thrombosis (DVT) is the third most common cardiovascular disease. Its clinical
therapeutic effect is unsatisfactory due to the high rate of postthrombotic syndrome. Several …

Background. The clinical treatment of coronary microvascular dysfunction (CMD) is mainly
based on conventional medicine, but the mechanism of the medicine is single and the …

Deep vein thrombosis (DVT) is a common complication in hematologic malignancies and
immunologic disorders. Endothelial cell injury and dysfunction comprise the critical …

Uvaol alleviates oxidative stress induced human umbilical vein endothelial cell injury by
suppressing mitogen-activated protein Page 1 BCF-23-221 Uvaol alleviates oxidative stress …

Deep vein thrombosis (DVT) is a common and fatal disease with a pathology involving
endothelial dysfunction. The present research aimed to address the potential clinical …

Background: Deep vein thrombosis (DVT) commonly occurs among vascular diseases
globally, for which circular RNAs (circRNAs) are becoming a promising option by mediating …

The aim. To examine the significance of microribonucleic acids (miRNAs) and oxidative
stress markers in predicting the onset of atherosclerosis and the connection between …